Patent details

LUC50035 Product Name: Élinzanétant

Basic Information

Publication number:
LUC50035
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP167231075
Legal Status:
Pending & Published
Application number:
LUC50035
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/25/1991
Marketing Authorization Type:
Marketing Authorization Date:
18/11/2025
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
20/01/2026
First Marketing Authorization date:
18/11/2025
Grant date:
Activation date:
Publication date:
21/01/2026
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
18/11/2040
SPC Extension Expiration:
18/11/2040
Rejection date:
Withdrawal date:

Owner

From:
20/01/2026
 
 

Name:
KANDY THERAPEUTICS LIMITED
Address:
400 South Oak Way, Reading, RG2 6AD, Berkshire, United Kingdom (GB)

Agent

Name:
ARONOVA S.A.
From:
20/01/2026
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Publication

Bulletin

Bulletin Heading:
SPC1
Bulletin edition number:
2026/03
Publication date:
05/02/2026
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

Annual Fees

Annual Fee Due Date:
02/06/2036
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
20/01/2026 Application Form 5
20/01/2026 General Document 36
20/01/2026 General Document 1
20/01/2026 Outgoing Correspondence 2
20/01/2026 General Document 1
20/01/2026 Marketing authorization 3
21/01/2026 Outgoing Correspondence 1
20/01/2026 MA publication 13
21/01/2026 Publication 1